Tracking

Thursday 8 April 2021

CCC publication: Ipilimumab and nivolumab (I+N) as first-line treatment of metastatic renal cell carcinoma (mRCC): A real-world review in North West of England, United Kingdom

Citation: Journal of Clinical Oncology. 2021, 39(6)
Author: Allison J.; Griffiths R.; Waddell T.; Pillai M.R.